Sexually Transmitted Diseases:
Letter to the Editor
“Doctor, How Long Has My Chlamydia Been There?” Answer: “…. Years”
Fairley, Christopher K. MBBS, PhD, FAFPHM, FACSHP*; Gurrin, Lyle BSc (Hons), PhD†; Walker, Jennifer BAppSc, MPH†; Hocking, Jane S. MPH, MHlthSc, PhD‡
*Department of Public Health, Melbourne Sexual Health Centre, firstname.lastname@example.org; †School of Population Health; and the ‡Key Centre for Women’s Health in Society, University of Melbourne, Victoria, Australia
To the Editor:
What would you say if an asymptomatic 24-year-old woman who tested positive for chlamydia asked you how long she has had it? We say several “years.” In fact, in the absence of antibiotics prescribed for other reasons or prior testing for chlamydia, we would argue that there is about a 25% chance the infection has been present for 2 or more years!
We base our argument on 2 published cohort studies.1,2 The largest was undertaken in the early 1990s in Bogata, Columbia, where a random community-based sample of women had cervical specimens collected over a period of up to 5 years as part of a natural history study of human papillomavirus infection.1 Women were included if they tested positive for chlamydia and had follow-up samples available. Two women were excluded because they received chlamydia-sensitive antibiotics during the study. The study showed that about 50% of infections had cleared by 1 year, 80% by 2 years, and 90% by 3 years. Similar findings were reported in other cohort studies, while some other studies suggest clearance rates may be higher.2–6
Using the data from the study by Molano and colleagues,1 we can use Bayes’ Theorem to generate a probability distribution for the duration of infection via the formula:
Equation (Uncited)Image Tools
is proportional to
Equation (Uncited)Image Tools
In this equation, we approximate the probability that a woman is tested and test positive given she contracted the infection x years ago by the proportion of woman with unresolved infection at x years (Molano et al.1) and assume that for an arbitrary infected woman, who may or may not have been tested, that the infection could have been contracted at any time in the recent past. We used this to calculate the probability that a woman has retained the infection for more than 1 year, 2 years, and so on.
We have provided 2 estimates; the first assumes that no infection lasts longer than 3.5 years (the longest follow-up time recorded by Molano et al.1) whereas the second, more reasonable scenario assumes infections continue to resolve for up to 5 years, when the proportion still positive is 3%, but all resolve at this point (Table 1). These calculations assume that an infected asymptomatic woman is equally likely to present for testing at any stage during her infection. They are clearly not valid if, for example, the women has presented for testing because she has symptoms or if she has a partner who recently tested positive for chlamydia. They can, however, be applied to any asymptomatic woman who is screened for chlamydia as part of a screening program, providing she has not had antibiotics for another unrelated condition or has not been tested for some years. These data suggest that there is reasonable probability that she may have had the infection for at least 18 months.
These data are particularly valuable when discussing positive results with a woman, largely because of the implications for her sexual relationships. Younger people are more likely to have more than one new sexual partner in the last 12 months and also to have relationships of shorter duration.7,8 Therefore, it is quite possible that a young woman may have acquired her infection from a previous sexual partner two or even three years ago. This information should be passed on to asymptomatic women diagnosed with chlamydia, as it could help prevent the potential destructive repercussions with current sexual partners that may arise if she believes that her infection had been recently acquired. This information should be included in any chlamydia education material targeting both clinicians and the general public and may help reduce any harm associated with screening.
1. Molano M, Meijer CJLM, Weiderpass E, et al. The natural course of chlamydia trachomatis infection in asymptomatic Colombian women: A 5-year follow-up study. J Infect Dis 2005;191:907–916.
2. Morre SA, van den Brule AJC, Rozendaal L, et al. The natural course of asymptomatic Chlamydia trachomatis infections: 45% clearance and no development of clinical PID after one-year follow up. Int J STD AIDS 2002;13(suppl 2):12–18.
3. Foglia G, Rhodes P, Goldberg M, et al. Completeness of and duration of time before treatment after screening women for Chlamydia trachomatis infections. Sex Transm Dis 1999;26:421–425.
4. Joyner JL, Douglas JM Jr, Foster M, et al. Persistence of Chlamydia trachomatis infection detected by polymerase chain reaction in untreated patients. Sex Transm Dis Apr 2002;29(4):196–200.
5. Parks KS, Dixon PB, Richey CM, Hook EW, 3rd. Spontaneous clearance of Chlamydia trachomatis infection in untreated patients. Sex Transm Dis 1997;24:229–235.
6. McCormack WM, Alpert S, McComb DE, et al. Fifteen-month follow-up study of women infected with Chlamydia trachomatis. N Engl J Med 1979;300:123–125.
7. Johnson AM, Mercer CH, Erens B, et al. Sexual behavior in Britain: partnerships, practices and HIV risk behaviours. Lancet 2001;358:1835–1842.
8. de Visser RO, Smith A, Rissel C, et al. Heterosexual experience and recent heterosexual encounters among a representative sample of adults. Aust NZ J Public Health 2003;27:146–154.
This article has been cited 2 time(s).
Biology of ReproductionMale genital tract chlamydial infection: implications for pathology and infertilityBiology of Reproduction
Sexually Transmitted InfectionsPrevalence, incidence and risk factors for pharyngeal chlamydia in the community based Health in Men (HIM) cohort of homosexual men in Sydney, AustraliaSexually Transmitted Infections
© Copyright 2007 American Sexually Transmitted Diseases Association